# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Jayson Bedford maintains DexCom (NASDAQ:DXCM) with a Strong Buy and raises the price target from $151 ...
Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $144 t...